First Adult Safety Trial on Nasal Live Attenuated B. Pertussis Vaccine

This study has been completed.
Sponsor:
Collaborators:
European Union
Swedish Institute for Infectious Disease Control
Innogenetics
Information provided by (Responsible Party):
Institut National de la Santé Et de la Recherche Médicale, France
ClinicalTrials.gov Identifier:
NCT01188512
First received: August 24, 2010
Last updated: January 27, 2012
Last verified: January 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: January 2012
  Primary Completion Date: June 2011 (Final data collection date for primary outcome measure)
No publications provided by Institut National de la Santé Et de la Recherche Médicale, France

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):